Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
0.5831
Dollar change
-0.0503
Percentage change
-7.94
%
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand0.49M Perf Week-2.80%
Market Cap0.29M Forward P/E- EPS next Y-0.00 Insider Trans- Shs Float- Perf Month-48.85%
Income- PEG- EPS next Q0.00 Inst Own7.50% Short Float- Perf Quarter-89.04%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.03 Perf Half Y-94.45%
Book/sh0.12 P/B4.69 EPS next Y- ROA- Short Interest0.04M Perf Year-99.09%
Cash/sh2.59 P/C0.22 EPS next 5Y- ROE- 52W Range0.44 - 56.02 Perf YTD-98.16%
Dividend Est.- P/FCF- EPS past 5Y45.82% ROI- 52W High-98.96% Beta-0.01
Dividend TTM- Quick Ratio0.79 Sales past 5Y-15.17% Gross Margin- 52W Low33.77% ATR (14)0.18
Dividend Ex-Date- Current Ratio0.79 EPS Y/Y TTM- Oper. Margin- RSI (14)25.87 Volatility8.28% 17.85%
Employees41 Debt/Eq0.83 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price2.99
Option/ShortNo / Yes LT Debt/Eq0.67 EPS Q/Q- Payout- Rel Volume0.25 Prev Close0.63
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsNov 27 Avg Volume1.15M Price0.58
SMA20-11.90% SMA50-74.69% SMA200-92.89% Trades Volume285,775 Change-7.94%
Dec-04-24 08:30AM
Nov-12-24 09:30AM
Oct-30-24 08:30AM
Oct-25-24 09:45AM
Oct-22-24 08:30AM
08:30AM Loading…
Oct-03-24 08:30AM
Sep-25-24 08:30AM
Sep-24-24 08:45AM
Sep-20-24 04:00PM
04:00PM
Sep-12-24 08:30AM
Sep-09-24 08:30AM
Sep-06-24 04:00PM
Sep-05-24 08:30AM
Sep-03-24 08:30AM
05:15PM Loading…
Aug-28-24 05:15PM
01:50PM
Aug-15-24 01:00PM
11:30AM
Aug-13-24 04:30PM
Jul-31-24 08:00AM
Jul-22-24 08:00AM
Jul-09-24 07:39AM
May-15-24 08:30AM
May-06-24 01:01PM
11:32AM
11:07AM
10:37AM
08:30AM
Apr-04-24 10:37AM
08:32AM Loading…
08:32AM
Apr-02-24 08:30AM
Mar-19-24 08:30AM
Mar-18-24 08:30AM
Mar-01-24 08:30AM
Feb-27-24 05:15PM
Feb-22-24 09:32AM
Feb-15-24 08:30AM
Feb-14-24 08:30AM
Jan-29-24 08:30AM
Jan-18-24 08:30AM
Jan-04-24 08:30AM
Jan-03-24 08:30AM
Dec-22-23 08:30AM
Dec-19-23 08:00AM
Dec-18-23 11:15AM
Dec-13-23 06:30AM
Nov-28-23 11:05AM
Nov-27-23 08:45AM
Nov-14-23 10:00AM
Nov-02-23 01:30PM
Oct-25-23 08:00AM
Oct-24-23 08:45AM
Oct-23-23 08:00AM
Sep-27-23 08:00AM
Sep-05-23 08:30AM
Aug-29-23 08:30AM
Jul-31-23 08:30AM
Jul-06-23 09:08AM
May-24-23 09:00AM
May-04-23 06:29AM
Apr-26-23 08:30AM
Apr-19-23 08:00AM
Mar-30-23 04:15PM
Mar-28-23 08:05AM
Mar-22-23 08:30AM
Mar-16-23 12:00PM
Mar-07-23 08:30AM
Feb-23-23 08:30AM
Feb-21-23 08:30AM
Feb-14-23 08:30AM
Feb-13-23 04:15PM
Feb-07-23 08:30AM
Jan-30-23 08:30AM
Jan-20-23 08:30AM
Jan-19-23 08:30AM
Jan-17-23 08:30AM
Jan-12-23 06:50AM
Dec-12-22 09:00AM
Nov-30-22 06:43PM
Nov-28-22 08:00AM
Nov-22-22 08:00AM
Nov-21-22 05:55AM
Oct-26-22 08:30AM
Oct-03-22 08:30AM
Sep-13-22 09:30AM
Aug-22-22 08:30AM
Jul-25-22 08:30AM
Jul-08-22 08:30AM
Jun-07-22 04:00PM
Jun-02-22 06:10PM
May-31-22 10:00AM
May-23-22 08:30AM
May-18-22 08:30AM
May-03-22 08:30AM
Apr-26-22 08:45AM
Apr-21-22 08:00AM
Apr-06-22 10:03AM
08:30AM
Mar-29-22 08:30AM
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.